A US Appeals Court recently ruled that a patent on Takeda Pharmaceutical’s chemotherapy drug Velcade used to treat bone marrow cancer is valid. Velcade has been used to treat over 550,000 patients worldwide and equated to $1.13 billion of US… Continue Reading →
Although 999 is a short and easy emergency telephone number for anyone to remember, no matter their age, it is not always possible for an individual to dial the number safely without putting themselves in danger if they are with… Continue Reading →
The background to this case was that Eli Lilly owned a patent that claims within the patent the use of “pemetrexed disodium” in the manufacture of a medical treatment substance that when combined with vitamin B12 can be used as… Continue Reading →
The EU’s chief Brexit negotiator, Michel Barnier, recently suggested that the new London based unified patent court may have to move away from its current location in London after the UK leaves the EU. It has already been decided that… Continue Reading →
Eli Lilly & Co. developed and manufactures Cialis, a drug which treats erectile dysfunction. Eli Lilly has had an ongoing patent dispute with other companies producing generic versions of Cialis about the Eli Lilly’s patent on the unit dose of… Continue Reading →
Amazon’s recently patented a fashion mannequin that has the ability to change size to match a customer’s physique. This new fashion mannequin that includes an automated camera allows the time taken by a stylist to dress and photograph the mannequin… Continue Reading →
The full list of ministerial responsibilities in the Department for Business, Energy and Industrial Strategy was recently finalised and announced. It was revealed that Jo Johnson (brother of Boris Johnson) will continue in his role as Minister of State for… Continue Reading →
Amazon recently had a patent (originally filed in December 2015) published for what is described on the patent application as a “multi-level fulfillment center for unmanned aerial vehicles”. Due to the large size of traditional fulfilment centres (where goods are… Continue Reading →
A US jury recently ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc $235 million ($234.1 million in lost profits and $1.4 million in royalties) for infringing a patent covering its blood pressure drug Coreg. A US federal jury found… Continue Reading →
© 2025 Dawn Ellmore Employment's Blog — Powered by WordPress
Theme by Anders Noren — Up ↑